# FibroBiologics Announces Grant of European Patent for Fibroblast Delivery of Tumor Inhibitory Agents

- Source: PR Newswire M&A
- Published: 2026-11-05T13:30:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/fibrobiologics-announces-grant-of-european-patent-for-fibroblast-delivery-of-tumor-inhibitory-agents-302929786.html
- Canonical: https://groundlevelnews.com/story/fibrobiologics-announces-grant-of-european-patent-for-fibroblast-deliv-9ef6d5/

Newly Granted Patent Covers Methods of Preparing Fibroblasts to Home to Tumors and Carry Oncolytic Viruses and Other Anti-Cancer Agents HOUSTON, Nov. 5, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._